These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15561164)

  • 1. Nursing care of the client requiring percutaneous coronary intervention.
    Vlasic W
    Nurs Clin North Am; 2004 Dec; 39(4):829-44. PubMed ID: 15561164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of patients after percutaneous coronary interventions.
    Shoulders-Odom B
    Crit Care Nurse; 2008 Oct; 28(5):26-41; quiz 42. PubMed ID: 18827085
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment and prevention of restenosis after percutaneous coronary intervention. Balloons, stents, radioactive rays and drug-releasing stents].
    Maeng M; Thuesen L; Andersen HR
    Ugeskr Laeger; 2005 Aug; 167(33):3030-2. PubMed ID: 16109244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applying drug-eluting stents in clinical practice.
    King SB
    Am J Cardiol; 2007 Sep; 100(5A):25K-31K. PubMed ID: 17719350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
    Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.
    Newsome LT; Kutcher MA; Royster RL
    Anesth Analg; 2008 Aug; 107(2):552-69. PubMed ID: 18633035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug-eluting or bare-metal stents in interventional cardiology. Theory and practice].
    Er F; Erdmann E
    Med Klin (Munich); 2007 Jan; 102(1):30-2. PubMed ID: 17221349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Care for the cardiopathy patient after percutaneous coronary intervention].
    Barrera-Ramírez CF; Pineda Pompa LR; Guzmán CE
    Gac Med Mex; 2004; 140(6):619-27. PubMed ID: 15633569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restenosis related to percutaneous coronary intervention has been solved?
    Kivelä A; Hartikainen J
    Ann Med; 2006; 38(3):173-87. PubMed ID: 16720432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of sirolimus-eluting stents versus bare metal stents for diabetic patients undergoing elective percutaneous coronary intervention.
    Aoki J; Ong A; Rodriguez-Granillo G; VanMieghem C; Daemen J; Sonnenschein K; McFadden E; Sianos G; van der Giessen W; de Feyter P; van Domburg R; Serruys P
    J Invasive Cardiol; 2005 Jul; 17(7):344-8. PubMed ID: 16003016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous coronary intervention and drug-eluting stents.
    Yang YM; Moussa I
    CMAJ; 2005 Feb; 172(3):323-5. PubMed ID: 15684110
    [No Abstract]   [Full Text] [Related]  

  • 14. [Welcome cardiac protection. With 1 to 2 drinks daily, C-reactive protein decreases].
    Wepner U
    MMW Fortschr Med; 2002 Dec; 144(51-52):14. PubMed ID: 12596677
    [No Abstract]   [Full Text] [Related]  

  • 15. The paclitaxel-eluting stent in percutaneous coronary intervention: part I: background and clinical comparison to bare metal stents.
    Gruchalla KJ; Nawarskas JJ
    Cardiol Rev; 2006; 14(2):88-98. PubMed ID: 16493246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal trends in major angioplasty complications: technical issues and the case for on-site coronary surgery.
    Mishra KJ; Sage PR; Philpott AC; Zeitz CJ; Horowitz JD
    Intern Med J; 2006 Jul; 36(7):458-61. PubMed ID: 16780454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case against low-volume percutaneous coronary intervention centers.
    O'Neill WW
    Circulation; 2009 Aug; 120(7):546-8. PubMed ID: 19652088
    [No Abstract]   [Full Text] [Related]  

  • 18. Angina following percutaneous coronary intervention: in-stent restenosis.
    Throndson K; Sawatzky JA
    Can J Cardiovasc Nurs; 2009; 19(3):16-23. PubMed ID: 19694113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous coronary intervention in the 21st century - making surgeons irrelevant?
    Adams MR
    Crit Care Resusc; 2007 Dec; 9(4):370-3. PubMed ID: 18052903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current drug-eluting stents in complex patients and lesions.
    Elezi S; Dibra A; Schömig A; Kastrati A
    Minerva Cardioangiol; 2006 Feb; 54(1):5-22. PubMed ID: 16467738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.